Scientists from McMaster University and MIT have leveraged generative artificial intelligence to discover enterololin, a novel narrow-spectrum antibiotic targeting the Enterobacteriaceae family. This innovation exemplifies AI’s accelerated capability in navigating chemical space to design antibiotics with selective bacterial lethality, addressing antibiotic resistance challenges. The discovery heralds a new era in antibiotic development driven by machine learning-guided molecular design.